HomeClinical Trials
Finding and Understanding Clinical Trials
A clinical study examines the effectiveness of new treatments and provides doctors and researchers with data to develop and deliver new, more effective treatments. In a typical year, over one million people participate in clinical studies.
This site provides essential clinical trial information: how medical trials work; your rights as a participant; and learn how signing up for trials can provide access to the best medical facilities and specialists. Participate in a clinical study and you'll help not only yourself, but also the thousands of others who could benefit from the trial's results.
Find a Trial...
You can use this site to find clinical trials by location or by medical condition; see below. Also, by using the search box on the right of this page, you can narrow your search to zip code level.
Current Clinical Trial Listings:
Search results for Amyloidosis AND Recruiting
1)
Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL AmyloidosisAmyloidosis
2)
Study of Systemic Amyloidosis Presentation and PrognosisAmyloidosis
3)
Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-Diagnosed Light-Chain (AL)-AmyloidosisAmyloidosis
4)
The Effect of Diflunisal on Familial AmyloidosisFamilial Amyloid Polyneuropathy; Familial Amyloidosis
5)
The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin AmyloidosisTransthyretin-Associated Amyloidosis With Polyneuropathy
6)
Radioimmunoimaging of AL AmyloidosisRadioimmunoimaging; AL Amyloidosis
7)
Radioimmunoimaging of AL AmyloidosisPrimary Amyloidosis
8)
Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS)TTR-Associated Amyloidosis
9)
High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic AmyloidosisMultiple Myeloma and Plasma Cell Neoplasm
10)
Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom BurdenMultiple Myeloma; Primary Amyloidosis
11)
Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic AmyloidosisMultiple Myeloma and Plasma Cell Neoplasm
12)
Open-Label Phase 1/2 Study of VELCADE (Bortezomib) for Injection in Patients With Light-Chain (AL)-AmyloidosisAmyloidosis
13)
Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic AmyloidosisMultiple Myeloma and Plasma Cell Neoplasm
14)
Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart DysfunctionMultiple Myeloma and Plasma Cell Neoplasm
15)
Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic AmyloidosisMultiple Myeloma and Plasma Cell Neoplasm
16)
Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition DiseaseMultiple Myeloma and Plasma Cell Neoplasm
17)
Second Autologous Stem Cell Transplant in Treating Patients With Persistent or Recurrent Primary Systemic (AL) AmyloidosisMultiple Myeloma and Plasma Cell Neoplasm
18)
Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic AmyloidosisMultiple Myeloma and Plasma Cell Neoplasm
19)
The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With V122I or Wild-Type (Transthyretin) TTR Amyloid CardiomyopathyCardiomyopathy
20)
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsChildhood Germ Cell Tumor; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Neuroblastoma; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
